Premium
[O4–03–04]: REDUCED BASAL FOREBRAIN ATROPHY PROGRESSION IN DONEPEZIL‐TREATED PRODROMAL ALZHEIMER'S DISEASE PATIENTS
Author(s) -
Cavedo Enrica,
Grothe Michel J.,
Colliot Olivier,
Lista Simone,
Chupin Marie,
Dormont Didier,
Lehéricy Stephane,
Teipel Stefan J.,
Dubois Bruno,
Hampel Harald
Publication year - 2017
Publication title -
alzheimer's and dementia
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2017.07.433
Subject(s) - donepezil , nucleus basalis , basal forebrain , atrophy , placebo , acetylcholinesterase , medicine , acetylcholinesterase inhibitor , psychology , cholinergic neuron , pathology , neuroscience , cholinergic , endocrinology , dementia , disease , biology , biochemistry , alternative medicine , enzyme
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom